Low hepatitis B surface antigen levels signal minimal liver cancer risk, redefining 'partial cure'

Researchers from National Taiwan University Hospital and Academia Sinica have identified a simple blood marker that can reliably pinpoint chronic hepatitis B (CHB) patients at negligible risk of developing liver cancer.
👉 Full Story

The Liver King gets fact-checked by MD PhD Doctor
- Dodgers’ Blake Treinen Honors Charlie Kirk With Personalized Hat - Andrew Powell
- Dollar Scholar Asks: What’s the Difference Between Cost and Price, and Does It Even Matter?
- Elon Musk's Ambitious Plan: To Send One Million Humans to Mars within the Next Decade - Michael A. Medeiros
- America’s fragile drug supply chain is extremely vulnerable to climate change - Beth Mole
- The Evolution and Impact of Internet Jokes: A Closer Look at Prank.Chat - Bertha Stephens
- The Full Moons of 2024: A Comprehensive Guide to Their Names and Dates - Arya Chandran

Apple’s Thin Phone and Reduced Marketshare – DTH | Daily Tech Headlines
- The Left’s True Face Revealed: Victim-Blaming and More Over Charlie Kirk’s Assassination - Mike Robertson
- Is the Smithsonian Weaseling Out from White House Questions? - Brian T. Allen
- What Causes Osteoarthritis? The 3 Main Factors To Know - Lindsay Curtis
- Why the Left is So Hard to Defeat
- iOS 18 Elevates the iPhone with Unmatched Personalization and Intelligence - Michael A. Medeiros
- An Iconic Robert De Niro Performance Gets Unfairly Overlooked - Drew Dietsch